Access cutting-edge portal hypertension treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.
Access portal hypertension specialists in Philadelphia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related portal hypertension treatment provided free
This is an open-label, non-randomized trial that will be conducted at three clinical sites, Thomas Jefferson University (TJU), the Hospital of the University of Pennsylvania (HUP) and University of Bern (UB). Enrollment will be allocated into one of 4 different cohorts depending on the inclusion criteria for each cohort. Cohort 1: Patients scheduled for hepatic vein pressure gradient (HVPG) measurements will subsequently undergo two consecutive SHAPE (subharmonic aided pressure estimation) pro
Sponsor: Thomas Jefferson University
Check if you qualify for this portal hypertension clinical trial in Philadelphia, PA
If you're searching for portal hypertension treatment options in Philadelphia, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced portal hypertension specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.